PubMed

The trends in prostate specific antigen usage amongst United Kingdom urologists--a questionnaire based study.

Burden HP, Davis CR, Tate S, Persad R, Holmes CH, Whittington K.

BMC Urol. 2008 Nov 20;8:17.PMID: 19021912 [PubMed - indexed for MEDLINE]Related articlesFree article

Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.

Jønler M, Eddy B, Poulsen J.

Scand J Urol Nephrol. 2005;39(3):214-8.PMID: 16118092 [PubMed - indexed for MEDLINE]Related articles

Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.

Bunting PS, Goel V, Williams JI, Iscoe NA.

CMAJ. 1999 Jan 12;160(1):70-5.PMID: 9934349 [PubMed - indexed for MEDLINE]Related articlesFree article

Prostate biopsy in Switzerland: a representative survey on how Swiss urologists do it.

Leippold T, Preusser S, Engeler D, Inhelder F, Schmid HP.

Scand J Urol Nephrol. 2008;42(1):18-23. Epub 2007 Aug 2.PMID: 17853010 [PubMed - indexed for MEDLINE]Related articles

Usefulness of prostate-specific antigen velocity in screening for prostate cancer.

Ito K, Yamamoto T, Ohi M, Kubota Y, Fukabori Y, Kurokawa K, Suzuki K, Yamanaka H.

Int J Urol. 2002 Jun;9(6):316-21.PMID: 12110095 [PubMed - indexed for MEDLINE]Related articles

Prostate-specific antigen testing practices and outcomes.

Hoffman RM, Blume P, Gilliland F.

J Gen Intern Med. 1998 Feb;13(2):106-10.PMID: 9502370 [PubMed - indexed for MEDLINE]Related articlesFree article

Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff.

Luboldt HJ, Bex A, Swoboda A, Hüsing J, Rübben H; Early Detection Project Group of the German Urological Association.

Eur Urol. 2001 Feb;39(2):131-7.PMID: 11223671 [PubMed - indexed for MEDLINE]Related articles

Initiation of salvage therapy for prostate cancer.

Johnstone PA, Booth R, Riffenburgh RH, Amling CL, Kane CJ, Moul JW.

Prostate Cancer Prostatic Dis. 2002;5(2):136-43.PMID: 12497004 [PubMed - indexed for MEDLINE]Related articlesFree article

Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists.

Fowler FJ Jr, Bin L, Collins MM, Roberts RG, Oesterling JE, Wasson JH, Barry MJ.

Am J Med. 1998 Jun;104(6):526-32.PMID: 9674714 [PubMed - indexed for MEDLINE]Related articles

Effect of guidelines on primary care physician use of PSA screening: results from the Community Tracking Study Physician Survey.

Guerra CE, Gimotty PA, Shea JA, Pagán JA, Schwartz JS, Armstrong K.

Med Decis Making. 2008 Sep-Oct;28(5):681-9. Epub 2008 Jun 12.PMID: 18556635 [PubMed - indexed for MEDLINE]Related articles

Prostate-specific antigen testing: uncovering primary care influences.

Gormley GJ, Catney D, McCall JR, Reilly PM, Gavin AT.

BJU Int. 2006 Nov;98(5):996-1000.PMID: 17034601 [PubMed - indexed for MEDLINE]Related articles

Screening for prostate cancer: a comparison of urologists and primary care physicians.

McKnight JT, Tietze PH, Adcock BB, Maxwell AJ, Smith WO, Nagy MC.

South Med J. 1996 Sep;89(9):885-8.PMID: 8790311 [PubMed - indexed for MEDLINE]Related articles

PSA testing in office-based clinics: are we testing as much as we think?

González HM, West B, Underwood W 3rd.

J Am Coll Surg. 2005 Dec;201(6):906-12. Epub 2005 Oct 13.PMID: 16310694 [PubMed - indexed for MEDLINE]Related articles

Prostate-specific antigen half-life and pretreatment prostate-specific antigen: crucial predictors for prostate-specific antigen trend in delayed-combined androgen blockade therapy.

Soga N, Onishi T, Arima K, Sugimura Y.

Int J Urol. 2007 Mar;14(3):192-6; discussion 197.PMID: 17430253 [PubMed - indexed for MEDLINE]Related articles

PSA testing: are patients aware of what lies ahead?

Lamplugh M, Gilmore P, Quinlan T, Cornford P.

Ann R Coll Surg Engl. 2006 May;88(3):284-8.PMID: 16720000 [PubMed - indexed for MEDLINE]Related articlesFree article

Brief report: physicians and their personal prostate cancer-screening practices with prostate-specific antigen. A national survey.

Chan EC, Barry MJ, Vernon SW, Ahn C.

J Gen Intern Med. 2006 Mar;21(3):257-9.PMID: 16637825 [PubMed - indexed for MEDLINE]Related articlesFree article

Recommended prostate-specific antigen testing intervals for the detection of curable prostate cancer.

Carter HB, Epstein JI, Chan DW, Fozard JL, Pearson JD.

JAMA. 1997 May 14;277(18):1456-60.PMID: 9145718 [PubMed - indexed for MEDLINE]Related articles

The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy: a survey of practice patterns of urologists and radiation oncologists in the United States.

Sylvester J, Grimm P, Blasco J, Meier R, Spiegel J, Heaney C, Cavanagh W.

Urology. 2001 Aug;58(2 Suppl 1):65-70. Review.PMID: 11502452 [PubMed - indexed for MEDLINE]Related articles

To screen or not to screen, when clinical guidelines disagree: primary care physicians' use of the PSA test.

Purvis Cooper C, Merritt TL, Ross LE, John LV, Jorgensen CM.

Prev Med. 2004 Feb;38(2):182-91.PMID: 14715210 [PubMed - indexed for MEDLINE]Related articles

Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations.

Eastham JA, Riedel E, Scardino PT, Shike M, Fleisher M, Schatzkin A, Lanza E, Latkany L, Begg CB; Polyp Prevention Trial Study Group.

JAMA. 2003 May 28;289(20):2695-700.PMID: 12771116 [PubMed - indexed for MEDLINE]Related articlesFree article